Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 5-benzylaminomethyl-6-aminopyrazolo [3, 4 -B] pyridine derivatives as cholesteryl ester-transfer protein (CETP) inhibitors useful for the treatment of atherosclerosis

5-benzylaminomethyl-6-aminopyrazolo [3, 4 -B] pyridine derivatives as cholesteryl ester-transfer protein (CETP) inhibitors useful for the treatment of atherosclerosis

US Patent 9000007 · Granted Apr 7, 2015

Estimated economic value: $8,741,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2017
Benzylamine derivatives and their utility as cholesterol ester-transfer protein 2017
Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (2016
Substituted heterocyclic amine compounds as cholesteryl ester-transfer protein (2016
Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (C2015
Substituted heterocyclic amine compounds as cholestryl ester-transfer protein (C2015
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2015
Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibit2013
5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the t2011
Crystalline form of 5(S)-(2-hydroxyethoxy)-20(S)-camptothecin2009
5(S)-(2′-hydroxyethoxy)-20(S)-camptothecin and its preparation and use for the t2009